433 related articles for article (PubMed ID: 17462514)
1. Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians.
Kaur G; Singh P; Rapthap CC; Kumar N; Vajpayee M; Sharma SK; Wanchu A; Mehra NK
Hum Immunol; 2007 May; 68(5):454-61. PubMed ID: 17462514
[TBL] [Abstract][Full Text] [Related]
2. Association of IL-4 589 C/T promoter and IL-4RalphaI50V receptor polymorphism with susceptibility to HIV-1 infection in North Indians.
Chatterjee A; Rathore A; Dhole TN
J Med Virol; 2009 Jun; 81(6):959-65. PubMed ID: 19382262
[TBL] [Abstract][Full Text] [Related]
3. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
Paxton WA; Kang S; Koup RA
AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S89-92. PubMed ID: 9581891
[TBL] [Abstract][Full Text] [Related]
4. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children.
Ometto L; Bertorelle R; Mainardi M; Zanchetta M; Tognazzo S; Rampon O; Ruga E; Chieco-Bianchi L; De Rossi A
J Infect Dis; 2001 Mar; 183(5):814-8. PubMed ID: 11181160
[TBL] [Abstract][Full Text] [Related]
6. Analysis of CCR5 and SDF-1 genetic variants and HIV infection in Indian population.
Gupta A; Padh H
Int J Immunogenet; 2015 Aug; 42(4):270-8. PubMed ID: 26096543
[TBL] [Abstract][Full Text] [Related]
7. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
8. CCR5 promoter polymorphisms and HIV-1 perinatal transmission in Brazilian children.
de Souza PR; Arraes LC; de Lima Filho JL; Bruneska D; Milanese M; Crovella S
J Reprod Immunol; 2006 Feb; 69(1):77-84. PubMed ID: 16233918
[TBL] [Abstract][Full Text] [Related]
9. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
[TBL] [Abstract][Full Text] [Related]
10. [Single nucleotide polymorphisms of HIV coreceptor CCR5 gene in Chinese Yi ethnic group and its association with HIV infection].
Ma LY; Hong KX; Lu XZ; Qin GM; Chen JP; Chen KL; Ruan YH; Xing H; Zhu JH; Shao YM
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3181-5. PubMed ID: 16405836
[TBL] [Abstract][Full Text] [Related]
11. [Identification of new mutant sites and 894C deletion variant genotyping of HIV-1 coreceptor CCR5 in indigenous Chinese populations].
Liu M; Wang F; Hong W; Wang B; Jin L; Lei Z; Hou J
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1468-72. PubMed ID: 12509908
[TBL] [Abstract][Full Text] [Related]
12. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
13. Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression.
Knudsen TB; Kristiansen TB; Katzenstein TL; Eugen-Olsen J;
J Med Virol; 2001 Nov; 65(3):441-4. PubMed ID: 11596075
[TBL] [Abstract][Full Text] [Related]
14. Association of RANTES -403 G/A, -28 C/G and In1.1 T/C polymorphism with HIV-1 transmission and progression among North Indians.
Rathore A; Chatterjee A; Sivarama P; Yamamoto N; Singhal PK; Dhole TN
J Med Virol; 2008 Jul; 80(7):1133-41. PubMed ID: 18461620
[TBL] [Abstract][Full Text] [Related]
15. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
Salem AH; Batzer MA
Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
[TBL] [Abstract][Full Text] [Related]
16. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
Teixeira SL; Bastos FI; Hacker MA; Morgado MG
Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
[TBL] [Abstract][Full Text] [Related]
17. Distribution of the mutated delta 32 allele of the CCR5 gene in a Sicilian population.
Sidoti A; D'Angelo R; Rinaldi C; De Luca G; Pino F; Salpietro C; Giunta DE; Saltalamacchia F; Amato A
Int J Immunogenet; 2005 Jun; 32(3):193-8. PubMed ID: 15932625
[TBL] [Abstract][Full Text] [Related]
18. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
[TBL] [Abstract][Full Text] [Related]
19. [Association between CCR5 promoter polymorphisms and hepatitis B virus infection].
Chang HY; Ahn SH; Kim DY; Shin JS; Kim YS; Hong SP; Chung HJ; Kim SO; Yoo WD; Han KH
Korean J Hepatol; 2005 Jun; 11(2):116-24. PubMed ID: 15980670
[TBL] [Abstract][Full Text] [Related]
20. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users.
Barber Y; Rubio C; Fernández E; Rubio M; Fibla J
J Infect Dis; 2001 Nov; 184(10):1279-88. PubMed ID: 11679916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
